Working Group Meeting, September 10-11, 2012 Agenda
Atlanta, Georgia
| Time | Activity | Speaker |
|---|---|---|
| 8:30 | Closed Session called to order | Ned Calonge, Chair |
| 8:30– 8:45 | Welcome and Opening Statement | Ned Calonge |
| 8:45 – 9:00 | Status updates and review of briefing book materials | Dave Dotson |
| 9:00 – 9:15 | CDC updates | Muin Khoury |
| 9:15 – 10:15 | Whole Genome Sequencing discussion | Katrina Goddard &
Ned Calonge |
| 10:15 – 10:30 | Break | |
| 10:30 – 12:00 | Familial Hypercholesterolemia | Katrina Goddard |
| 12:00 – 1:00 | Lunch | |
| 1:00 – 2:00 | CYP2C19 Testing/Anti-platelet therapy (Clopidigrel) – review & recommendation | EPC Representative &
Michael Douglas |
| 2:00 – 3:30 | CRC collaboration planning discussion | Muin Khoury &
Ned Calonge |
| 3:30 – 3:45 | Break | |
| 3:45 – 5:00 | CRC collaboration planning (continued) | Dave Dotson |
| 5:00 – 5:15 | Wrap-up and Adjourn Closed Session | Ned Calonge |
| Time | Activity | Speaker |
|---|---|---|
| 9:00 | Open Session called to order | Ned Calonge |
| 9:00 – 9:15 | Overview of Day 1, brief staff updates and outstanding questions | Ned Calonge & Staff |
| 9:15 – 9:45 | CYP450 Update Report | Dave Dotson |
| 9:45 – 10:15 | Prostate Cancer SNP Panel Recommendation | Dave Dotson |
| 10:15 – 10:45 | Break | |
| 10:45 – 11:45 | Prostate Cancer / PCA3 – review & recommendation | Glenn Palomaki &
Michael Douglas |
| 11:45 – 12:00 | Public Comment | |
| 12:00 – 1:00 | Wrap Up and Action Items | Ned Calonge & Staff |
| 1:00 | Adjourn CLOSED SESSION | Ned Calonge |